T1	Participants 80 130	288 parasitologically proved patients of kala-azar
T2	Participants 158 180	three treatment groups
T3	Participants 182 211	Patients in groups A, B and C
T4	Participants 409 421	all patients
T5	Participants 450 491	96 (100%), 92 (96%) and 84 (88%) patients
T6	Participants 508 525	groups A, B and C
T7	Participants 593 667	95 (99%), 87 (91%) and 79 (82%) patients in groups A, B and C respectively
T8	Participants 717 729	three groups
T9	Participants 999 1011	three groups
T10	Participants 1113 1138	Indian kala-azar patients
